We tested prospectively for hepatitis C virus (HCV) in one orthopaedic surgeon's operative practice for one year.
Of 425 consecutive patients, 19 (4.5%) were positive for HCV infection using a second-generation screening assay.
The highest correlation with a positive test was the presence of tattoos and the second highest was intravenous drug abuse, but only after a second interview, since most patients did not report this risk on the initial questionnaire.
Based on the criteria of the US Public Health Services algorithm, nine (47%) of the patients with a positive initial screening test or 2.2% of the 425 patients, had hepatitis C (both anti-HCV-positive and elevated alanine aminotransferase).
In this group of nine, the presence of tattoos had the highest and intravenous drug abuse the second highest correlation, also after the second interview.
There is no vaccine available for the prevention of HCV infection, and prophylactic immunoglobulin therapy has no proven value for primary exposure.
Mots-clés Pascal : Appareil circulatoire pathologie, Epidémiologie, Homme, Chirurgie orthopédique, Hépatite virale C, Virose, Infection, Foie pathologie, Incidence, Service hospitalier, Washington, Etats Unis, Amérique du Nord, Amérique
Mots-clés Pascal anglais : Cardiovascular disease, Epidemiology, Human, Orthopedic surgery, Viral hepatitis C, Viral disease, Infection, Hepatic disease, Incidence, Hospital ward, Washington, United States, North America, America
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 96-0001023
Code Inist : 002B05C02G. Création : 01/03/1996.